The purpose of this study was to determine the effect of long-term Cr supplementation on blood parameters reflecting liver and kidney function. Twentythree members of an NCAA Division II American football team (ages = 19-24 years) with at least 2 years of strength training experience were divided into a Cr monohydrate group (CrM, n = 10) in which they voluntarily and spontaneously ingested creatine, and a control group (n = 13) in which they took no supplements. Individuals in the CrM group averaged regular daily consumption of 5 to 20 g (mean ± SD = 13.9 ± 5.8 g) for 0.25 to 5.6 years (2.9 ± 1.8 years). Venous blood analysis for serum albumin, alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase, bilirubin, urea, and creatinine produced no significant differences between groups. Creatinine clearance was estimated from serum creatinine and was not significantly different between groups. Within the CrM group, correlations between all blood parameters and either daily dosage or duration of supplementation were nonsignificant. Therefore, it appears that oral supplementation with CrM has no long-term detrimental effects on kidney or liver functions in highly trained college athletes in the absence of other nutritional supplements.
Introduction
A growing body of research supports the use of exogenous creatine monohydrate (CrM) supplementation as a means of boosting athletic performance (7, 13, 15, 23, 24, 39, 40, 43) . Particularly, CrM has been used to enhance performance of repeated bouts of high intensity exercise. In efforts to increase performance, many athletes from high school to professional levels have turned to this ergogenic aid as a means of enhancing training and performance capacities (36, 37), many times without regard for potential side effects.
Weight gain is often described as the main side effect of CrM supplementation (12, 22, 45) . Speculation indicates that this phenomenon is due to water retention (2, 7) . Coupled with this may be a reduction in urine output that may place greater strain on kidney function. Information on other potential side effects may be limited to anecdotal information (33), case studies (14, 18, 20, 29) , and short-term investigations (12, 22, 27, 32, 35, 44) . The most common side effects reported anecdotally and in group investigations include muscle cramps, headaches, diarrhea, and gastrointestinal pain (10, 11, 35) , while the case studies reported acute interstitial nephritis and, in a patient with existing kidney dysfunction, steroid-responsive nephrotic syndrome (14, 29) . There have been concerns raised, however, that these case studies may be misleading due to, among other problems, the pre-existence of kidney diseases and/or misdiagnosis (9, 26, 28) . Since the liver is also involved in the synthesis of creatine, its normal production could be suppressed from the higher levels of creatine supplementation (10, 11) .
Recent interest in CrM as a sports supplement has created a growing body of research investigating the health consequences/side effects of CrM ingestion. Of primary interest among these are adverse hepatic and renal responses. Most of the studies investigating these effects have utilized supplement durations of 5 to 63 days (12, 22, 32) , while some studies extended to a duration of 1 year or longer (17, 25, 27, 35) . Outside of the athlete population, Vannas-Sulonen et al. (41) found that gyrate atrophy patients who consumed 1.5 g/d for 5 years showed no adverse side effects. No controlled group studies to date have indicated adverse effects on either kidney or liver function.
Due to the fact that long-term (>2 years) clinical trials involving CrM ingestion are difficult to perform from an administrative standpoint, perhaps other forms of investigation are warranted. A retrospective study incorporating participants who have voluntarily and spontaneously taken CrM would provide much needed preliminary long-term data on possible adverse affects of supplementation. The purpose of this study was to determine the long-term effects of CrM supplementation on blood parameters reflecting liver and kidney functions in American college football players.
Methods
All members of an NCAA Division II American college football team (n = 88) reported the nature of their voluntary and spontaneous use of ergogenic supplements via a questionnaire. They were evaluated at the conclusion of a summer conditioning program prior to regular season training. Ten participants reported using only CrM as a training supplement for periods ranging from 0.25 to 5.6 years (mean ± SD = 2.9 ± 1.8 years). Average daily dosages were reported between 5 and 20 g (13.9 ± 5.8 g). Thirteen players who used no supplements whatsoever served as a control group. All other team members (n = 65) were excluded from the present study due to their use of other ergogenic aids. All participants had a minimum of 2 years of weight training experience. This study was approved by the Institutional Review Board for the Protection of Human Subjects at Truman State University.
A 10-ml blood sample was drawn from the antecubital vein by a certified phlebotomist. The samples were stored on ice until they were analyzed on the same day at a clinical hematology laboratory. Samples were analyzed using a Synchron CX ® 9 (Beckman Coulter, Inc., Miami, FL) that had a test-retest reliability within ±5% for all procedures. All samples were analyzed for serum creatinine (Crn), albumin, alkaline phosphatase (ALK P), alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin, and urea. Creatinine clearance was estimated using the formula: creatinine clearance (ml/min/m 2 ) = {[140 -age (years)] ϫ weight (kg)} / [72 ϫ plasma creatinine (mg/dl)] / (BSA) (4). Body surface area (BSA) was calculated using the formula: BSA (m 2 ) = weight (kg) 0.425 ϫ height (cm) 0.725 ϫ 0.007184. Independent t tests were used to compare data between groups, and Pearson correlations were used to determine relationships within the CrM group.
Results
The physical characteristics of the two groups were not significantly different (Table  1 ). In addition, none of the blood markers for liver and kidney function were significantly different between the groups (Table 1 ). All mean values for both groups, except for absolute serum Crn levels of the CrM group, fell within the normal limits given by the laboratory as acceptable (Table 2) .
In addition to the lack of significant difference between the CrM group and the control group in blood markers of kidney and liver function, the CrM group had no significant correlations between any blood parameters and either duration of use or dosage amount (Table 3) . Note. *t = 2.08 significant at the p < .05 level.
Discussion
From the results of this study, it appears that there are no detrimental effects of longterm CrM supplementation on liver or kidney functions as determined by normal clinical blood parameters, which coincide with previous research (1, 6, 16, 22, 27, 28, 30, 31). The CrM group was similar in all blood parameters to a control group in which participants had never ingested CrM or any other performance-enhancing supplements. The lack of significant relationships between CrM supplementation Note. *r = 0.632 significant at p < .05.
duration and blood parameters marking liver and kidney function would tend to indicate that there was no detrimental cumulative effect. Previous caution has been registered that high dosages of CrM would place an excess load on the renal system to clear CrM (14, 28) . Most of these observations have been case studies that have been criticized (9, 28) because these individuals had pre-existing kidney disease (29), may have been misdiagnosed (18, 20), or were ingesting a low-dose liquid form of CrM (20). Thus, it appears that the renal problems identified in these individuals were unrelated to CrM supplementation, and to associate the two factors may be erroneous. Additionally, studies that have evaluated the validity of altered renal function in response to CrM supplementation using Crn clearance (16, 45) and/or iohexol infusion (19) techniques to assess glomerular filtration have reported no problems in participants taking creatine for up to 5 years (retrospective) or 21 months (monitored).
In the current study, Crn clearance was estimated from serum Crn using the Cockcroft and Gault formula (4), which has been confirmed as a valid estimation of Crn clearance in normal non-athletes (34). An attempt was made to reduce potential error in this formula by normalizing the data to each athlete's respective body surface area rather than assuming a standard body surface area of 1.73 m 2 , which was small for this population. Kuel and colleagues (19), however, found that while both Crn clearance and iohexol infusion tracked changes in renal function, the Crn clearance method underestimated this function. Therefore, depending strictly on serum Crn levels to estimate renal function in CrM users undergoing high-volume training may be somewhat misleading.
Some studies have reported that CrM supplementation tended to increase serum Crn, thereby decreasing estimated Crn clearance (1, 21, 35, 42, 44) , while other research has not found this to be the case (6, 8, 22, 27, 30, 31) . However, the current study revealed no significant difference between the groups for both serum Crn and estimated Crn clearance. The lack of significant relationships between either CrM dosage or duration of usage and Crn clearance further suggests that supplementation does not impair renal function.
Several participants in both groups in the current study were outside of the clinical ranges for serum Crn, with the mean for serum Crn levels in the CrM group just above the clinical range. However, there was no significant difference between the groups, and it has been shown that larger individuals such as those in this population have greater absolute Crn amounts and greater Crn clearance (5). Since CrM is naturally degraded to Crn, any increase in serum Crn may simply reflect a greater turnover of creatine in response to increases in training volume and/or intensity (2, 22) . Therefore, increased serum Crn levels found in some studies may reflect the ability to maintain a greater training volume rather than as a direct consequence of supplementation.
Further investigation of these and other blood parameters on a larger sample of highly trained athletes is warranted. Additional study may be needed to determine the health implications of long-term CrM supplementation, particularly to determine potential interactions when combining multiple supplements (i.e., "stacking"). Also of interest may be the ramifications of CrM supplementation among individuals with pre-existing diseases and the safety for use in various medical populations currently being studied (3, 38) . While it seems there are no detrimental long-term effects in this population, it would be wise to seek the advise of a medical professional before engaging in any form of supplementation. 
